Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Hepatitis C

  Free Subscription


13.05.2019

1 Clin Res Hepatol Gastroenterol
1 Hepatology
2 J Infect Dis
2 J Viral Hepat
2 J Virol
3 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Clin Res Hepatol Gastroenterol

  1. SUN Q, Li J, Jin B, Wang T, et al
    Evaluation of miR-331-3p and miR-23b-3p as serum biomarkers for hepatitis c virus-related hepatocellular carcinoma at early stage.
    Clin Res Hepatol Gastroenterol. 2019 Apr 30. pii: S2210-7401(19)30088.
    PubMed     Text format     Abstract available


    Hepatology

  2. WRENSCH F, Ligat G, Heydmann L, Schuster C, et al
    IFITMs mediate viral evasion in acute and chronic hepatitis C virus infection.
    Hepatology. 2019 May 7. doi: 10.1002/hep.30699.
    PubMed     Text format     Abstract available


    J Infect Dis

  3. YAN Y, Wang X, Lou P, Hu Z, et al
    A nanoparticle-based HCV vaccine with enhanced potency.
    J Infect Dis. 2019 May 10. pii: 5487910. doi: 10.1093.
    PubMed     Text format     Abstract available

  4. LAIDLAW SM, Dustin LB
    An HCV vaccine on the fly.
    J Infect Dis. 2019 May 10. pii: 5487908. doi: 10.1093.
    PubMed     Text format    


    J Viral Hepat

  5. LITWIN AH, Drolet M, Nwankwo C, Torrens M, et al
    Perceived barriers related to testing, management and treatment of HCV infection among physicians prescribing opioid agonist therapy: The C-SCOPE Study.
    J Viral Hepat. 2019 May 9. doi: 10.1111/jvh.13119.
    PubMed     Text format     Abstract available

  6. GHOSH A, Mondal RK, Romani S, Bagchi S, et al
    Persistent Gamma Delta-T cell Dysfunction in Chronic HCV Infection Despite Direct Acting Antiviral Therapy Induced Cure.
    J Viral Hepat. 2019 May 9. doi: 10.1111/jvh.13121.
    PubMed     Text format     Abstract available


    J Virol

  7. QIN Y, Xun Z, Guo Y, Chen S, et al
    Sam68 Promotes Hepatitis C Virus Replication by Interaction with Stem-Loop 2 of Viral 5' Untranslated Region.
    J Virol. 2019 May 8. pii: JVI.00693-19. doi: 10.1128/JVI.00693.
    PubMed     Text format     Abstract available

  8. COLBERT MD, Flyak AI, Ogega CO, Kinchen VJ, et al
    Broadly neutralizing antibodies targeting new sites of vulnerability in hepatitis C virus E1E2.
    J Virol. 2019 May 8. pii: JVI.02070-18. doi: 10.1128/JVI.02070.
    PubMed     Text format     Abstract available


    PLoS One

  9. COSTA VD, Brandao-Mello CE, Nunes EP, Dos Santos Silva PGC, et al
    Treatment of chronic HCV infection with DAAs in Rio de Janeiro/Brazil: SVR rates and baseline resistance analyses in NS5A and NS5B genes.
    PLoS One. 2019;14:e0216327.
    PubMed     Text format     Abstract available

  10. COSSAIS S, Schwarzinger M, Pol S, Fontaine H, et al
    Quality of life in patients with chronic hepatitis C infection: Severe comorbidities and disease perception matter more than liver-disease stage.
    PLoS One. 2019;14:e0215596.
    PubMed     Text format     Abstract available

  11. BARANYI A, Meinitzer A, Rothenhausler HB, Amouzadeh-Ghadikolai O, et al
    Metabolomics approach in the investigation of depression biomarkers in pharmacologically induced immune-related depression.
    PLoS One. 2018;13:e0208238.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hepatitis C is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: